Sodium 1,4-bis((2-ethylhexyl)oxy)-1,4-dioxobutane-2-sulfonate

Catalog No. :
ACIRPE243
CAS No. :
577-11-7
Molecular Formula :
C20H37NaO7S
Molecular Weight :
444.57

IUPAC Name:sodium 1,4-bis((2-ethylhexyl)oxy)-1,4-dioxobutane-2-sulfonate

Sodium 1,4-bis((2-ethylhexyl)oxy)-1,4-dioxobutane-2-sulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium 1,4-bis((2-ethylhexyl)oxy)-1,4-dioxobutane-2-sulfonate
IUPAC Namesodium 1,4-bis((2-ethylhexyl)oxy)-1,4-dioxobutane-2-sulfonate
MDL No.MFCD00012455
Molecular FormulaC20H37NaO7S
Molecular Weight444.57
SMILESO=S(C(CC(OCC(CC)CCCC)=O)C(OCC(CC)CCCC)=O)([O-])=O.[Na+]
InChI KeyAPSBXTVYXVQYAB-UHFFFAOYSA-M
SynonymDiotilan | Dioctyl sulfosuccinate sodium salt | Dioctylal | Constonate | Molatoc | Molcer | Doxol | Bis(2-ethylhexyl) sulfosuccinate sodium salt | Docusate (Sodium) | Nevax | Soliwax | Dialose | Waxsol | Adekacol EC 8600 | Dioctyl sodium sulfosuccinate |
CAS No.577-11-7
PubChem CID23673837

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H315-H318-H402
Precautionary Statement(s)
P264-P273-P280-P302+P352-P305+P351+P338+P310-P332+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACIRPE243 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUDFV444 route compound structure diagram
    ACUDFV444115960-17-3 In Stock
  4. Then
  5. ACIRPE243 route product structure diagram
    ACIRPE243577-11-7
Inquiry

2. ACIRPE243 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIRPE243 route product structure diagram
    ACIRPE243577-11-7
Inquiry

Comments (0)